Your session is about to expire
← Back to Search
DHA Supplements for Tardive Dyskinesia
Study Summary
This trial is testing whether DHA supplements can help reduce involuntary movements caused by tardive dyskinesia, a complication from antipsychotic drugs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have symptoms of tardive dyskinesia according to specific research criteria, such as muscle movements in at least two body areas or more intense movements in one body area.I regularly take aspirin, blood thinners, or cholesterol medication.I understand the study's goals and can give informed consent.Your triglyceride levels are higher than 4.0 mmol/L or your cholesterol levels are higher than 8 mmol/L when you haven't eaten for a while.You are taking supplements with omega-3 fatty acids from fish or plants.I have been on stable schizophrenia treatment for at least 3 months.You have used illegal drugs in the past year.I am not pregnant or breastfeeding.I do not have heart disease, pancreatitis, diabetes, bleeding disorders, or conditions that increase bleeding risk.I will use effective birth control during the study.
- Group 1: 2
- Group 2: 1
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What selection criteria are necessary to participate in this experiment?
"This medical trial is looking for 40 individuals between 30 and 75 years of age that have been diagnosed with tardive dyskinesia. Key eligibility criteria include a history of chronic schizophrenia receiving antipsychotic drugs over 3 months, presence of mild to moderate intensity Schooler-Kane research criteria in two body parts or more, capacity to understand the goals and procedures involved as well as providing informed consent; female participants must also utilize an effective contraceptive method throughout this study's duration."
Is the enrollment period for this trial still open?
"The details on clinicaltrials.gov demonstrate that this trial is not currently enrolling, as the last edit was made back in February of 2008. Although recruitment has been suspended for now, 32 other trials are actively welcoming new patients at present."
Is this research endeavor seeking volunteers aged 25 and over?
"Per the inclusion criteria, this clinical trial seeks patients aged 30 to 75. In addition, there are 11 trials for minors and 28 studies that cater to seniors."
Is the FDA sanctioning Omega-3 fish oil capsules (including DHA) as an acceptable medication?
"The safety of Omega-3 fish oil capsules, including DHA, was ranked a 2 due to the preclinical data suggesting its security but lack of evidence indicating efficacy."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger